Does the article say anything more then that? Based on earnings for 2013 and 2014 I would not say we are overvalued. Now if it is based on future possibilities then maybe it is undervalued at this time. Based on past Maribivar, HCV 796, etc. outcomes I won't count the chickens at least before the eggs are layed. Hopefully we will get some positive Maribivar news in Q2
Report points out very strong fundamentals and over estimated concern about Cinryze erosion in 2014,does not even take into account roll out of new products and geographic expatiation of current products.